- 6-12 months comprehensive program
- 3-6 months for skin softening; ongoing organ monitoring
- 75%
China versus the U.S.
- China clinical rate
- $1,000 – $4,500
- $2,750
- United States
- $4,000 – $18,000
- $11,000
- You save
- ~75%
- $8,250 per procedure
Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.
What the procedure involves.
Multisystem scleroderma management targeting skin fibrosis, Raynaud's phenomenon, and internal organ involvement. Chinese rheumatology centers combine antifibrotic agents and immunosuppressants with TCM blood-activating therapies that may help improve microcirculation. Treatment programs include vascular assessments, pulmonary function monitoring, and specialized skin care.
Step by step.
Systemic Assessment
Skin score evaluation, nailfold capillaroscopy, pulmonary function tests, echocardiography, and autoantibody profiling
Immunosuppressive Therapy
Mycophenolate or methotrexate for skin and lung fibrosis; nintedanib for progressive lung disease
Vascular Management
Calcium channel blockers, PDE5 inhibitors, or iloprost for Raynaud's and digital ulcers
TCM Blood-Activating Therapy
Herbal formulas to promote microcirculation, reduce fibrosis, and warm meridians (Danggui Sini Tang)
- TCM blood-activating herbs complement vascular management
- Affordable antifibrotic and immunosuppressive medications
- Comprehensive multiorgan screening and monitoring
- Access to autologous stem cell transplant for severe cases
- Progressive organ fibrosis despite treatment
- Pulmonary hypertension development
- Digital ulceration and infection
- Renal crisis requiring emergency management
Ask the AI for hospitals that handle scleroderma treatment.
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.